Compugen (CGEN) Cash & Equivalents Growth (5y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.21% |
| Jun 30, 2025 | -12.33% |
| Dec 31, 2024 | 14.69% |
| Jun 30, 2024 | 13.78% |
| Dec 31, 2023 | 16.52% |
| Jun 30, 2023 | 9.31% |
| Dec 31, 2022 | -15.37% |
| Jun 30, 2022 | -13.12% |
| Dec 31, 2021 | -4.28% |
| Jun 30, 2021 | -6.15% |
| Dec 31, 2020 | -7.90% |
| Jun 30, 2020 | -13.40% |
| Dec 31, 2019 | -18.56% |
| Jun 30, 2019 | -26.35% |
| Dec 31, 2018 | -25.80% |
| Jun 30, 2018 | -3.53% |
| Dec 31, 2017 | 9.24% |
| Jun 30, 2017 | 13.99% |
| Dec 31, 2016 | 10.68% |
| Jun 30, 2016 | 8.10% |
| Dec 31, 2015 | 8.10% |
| Jun 30, 2015 | 11.12% |
| Dec 31, 2014 | 11.12% |
| Jun 30, 2014 | 43.96% |